Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Published in: Journal of diabetes investigation (2023)

Imeglimin is efficacious, safe, and well tolerated as monotherapy and adjunctive therapy.

Keyphrases